Skip to content

Global trade dispute: Ripple XRP emerges as a secret weapon

Ripple XRP is increasingly discussed as a potential key player in global trade, especially in times of trade disputes and trade conflicts that are straining international supply chains. XRP's ability to enable fast, cost-effective, and transparent cross-border transactions positions it as a viable solution for the challenges facing businesses and financial institutions in an increasingly fragmented global trade environment. This analysis highlights why and how Ripple XRP can offer a solution for optimizing trade flows in the context of current global trade disputes, supported by concrete facts and real-world examples. Background: Global trade disputes and their impact The world economy is currently experiencing a phase of increased trade tensions, characterized by trade disputes between major economic powers such as the USA, China, and the European Union. Since 2018, the USA and China have imposed tariffs on hundreds of billions of dollars worth of goods on each other, which… 

more »Global trade dispute: Ripple XRP emerges as a secret weapon

Link between diabetes and oral health confirmed in Germany

  • News

Berlin, 9. April 2025 – Eine aktuelle Studie des Robert Koch-Instituts (RKI) zeigt erstmals auf breiter Basis, dass Menschen mit Diabetes in Deutschland ihre Mundgesundheit deutlich schlechter wahrnehmen als Menschen ohne diese Erkrankung. Die Untersuchung, veröffentlicht im „Journal of Health Monitoring“, basiert auf Daten der bundesweiten Befragung „Gesundheit in Deutschland aktuell“ (GEDA 2019/2020-EHIS) und unterstreicht die enge Verbindung zwischen Diabetes mellitus und oraler Gesundheit. Die Ergebnisse der Studie verdeutlichen, dass rund 41 Prozent der Erwachsenen mit Diabetes ihren Zahn- und Zahnfleischzustand als mittelmäßig bis sehr schlecht einschätzen. Bei Personen ohne Diabetes liegt dieser Anteil bei etwa 28 Prozent. Besonders auffällig sind die Unterschiede zwischen den Geschlechtern: Während bei Männern mit Diabetes fast die Hälfte eine schlechte Mundgesundheit angibt, sind es bei Frauen etwas über ein Drittel. Selbst nach Berücksichtigung von Faktoren wie Alter, Bildung, Rauchen oder Body-Mass-Index bleibt der Zusammenhang… 

more »Zusammenhang zwischen Diabetes und Mundgesundheit in Deutschland bestätigt

NeuroSense Therapeutics Announces Transformative Phase 2b MicroRNA Data

  • News

New miRNA findings unveiled at the AAN, reveal key biological mechanisms behind PrimeC’s clinical benefit in ALS. NeuroSense Therapeutics, Ltd. (NASDAQ: NRSN), a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced promising new findings from its Phase 2b PARADIGM clinical trial. The data highlights the significant impact of PrimeC, the company’s investigational therapy for the treatment of amyotrophic lateral sclerosis (ALS), on microRNA (miRNA) modulation. These data are particularly significant because they: Key Findings: This research, conducted in collaboration with Prof. Noam Shomron of Tel Aviv University’s Faculty of Medical and Health Sciences, a leader in microRNA research and functional genomics, was presented yesterday by Jeffrey Rosenfeld, M.D., Ph.D., Professor of Neurology and Associate Chairman of Neurology at Loma Linda University School of Medicine, during a Late Breaker session at the 77th Annual American Academy of Neurology (AAN) Meeting, in San Diego, CA.

Safer Alternative for Long-Term Hepatitis B Treatment

Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil fumarate (TDF) is currently the most widely used antiviral agent for CHB treatment. However, long-term use of TDF has adverse effects on kidney function and bone health. Now, a new study has shown that switching to the drug besifovir leads to improved renal and bone health in patients with CHB. Hepatitis B is a liver infection cause by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer than six months are considered „chronic“. Chronic hepatitis B (CHB) poses a huge healthcare burden as it is a common cause of chronic liver disease and is also associated with the development of liver cirrhosis and liver cancer. The antiviral tenofovir disoproxil fumarate (TDF) is currently the most widely used treatment for… 

more »Safer Alternative for Long-Term Hepatitis B Treatment

ZEISS receives FDA clearance for INTRABEAM 700

With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro tumor therapy. As a leading provider of medical solutions in the field of neurosurgery, ZEISS Medical Technology is also dedicated to shaping modern oncology. The company recently received 510(k) clearance from the US Food and Drug Administration (FDA) for INTRABEAM® 700 – a leading-edge platform that provides robotic-assisted precision to support intraoperative radiation therapy (IORT). With its modern digital-first architecture, ZEISS INTRABEAM 700 creates SMART workflow efficiency and provides seamless connectivity, offering real added value for neurooncology and breast cancer therapy. Robotic-assisted Precision In oncological treatments, it must be ensured that the target area is optimally resected, and that healthy tissue is spared as much as possible. Especially during contact irradiation, it is important that the target focus always remains the same throughout… 

more »ZEISS receives FDA clearance for INTRABEAM 700

ProBio Sets New Standard in GMP Plasmid DNA Manufacturing with Guaranteed ? 85% Supercoiled DNA

ProBio, a global contract development and manufacturing organization (CDMO), is pleased to announce the launch of its GMP Plasmid DNA manufacturing service at its state-of-the-art facility in Hopewell. This new service guarantees the delivery of clinical-grade plasmid DNA production from cell bank to batch release in just three months. This is a significantly faster manufacturing time than is typical and can help accelerate the development of gene and cell therapies. The Hopewell facility, which has a rich legacy of biologics innovation, previously served as a research hub for a leading global pharmaceutical company and later as an AAV-based gene therapy manufacturing center. Now the centerpiece of ProBio’s operations, the site is led by a team of industry veterans with decades of experience in biologics and cell and gene therapies. By combining this expertise with ProBio’s proprietary platform technologies, the company ensures… 

more »ProBio Sets New Standard in GMP Plasmid DNA Manufacturing with Guaranteed ? 85% Supercoiled DNA

Fischschwimmblasen bei der Behandlung von Herzversagen nützlich

  • News

Hydrogele, weiche Materialien aus vernetzten Polymeren, könnten vielfältige medizinische Anwendungen finden. In einer in Advanced Science veröffentlichten Studie entwickelten Forscher ein injizierbares Hydrogel mit Bestandteilen der Fischschwimmblase und setzten es zur Reparatur von geschädigtem Herzgewebe ein. Die Schwimmblase eines Fisches ist ein Organ, das dem Fisch beim Schwimmen im Wasser hilft. Sie besteht aus Kollagen, Glykosaminoglykanen und Elastin und ähnelt stark Teilen des menschlichen Herzens. Experimente zeigten, dass das Hydrogel der Forscher auf Basis der Fischschwimmblase die Adhäsion und Dehnung von Herzzellen verbessert, die Bildung neuer Blutgefäße fördert und Immunzellen zur Bekämpfung von Entzündungen anregt. Das Hydrogel unterstützte zudem nachhaltig die Herzkontraktionen. Diese Effekte wurden nach der Hydrogelbehandlung in Zellkulturen und in einem Rattenmodell mit ischämischer Herzinsuffizienz beobachtet. „Der irreversible Verlust von Kardiomyozyten – oder Herzmuskelzellen – nach ischämischen Ereignissen unterstreicht den dringenden Bedarf an neuen regenerativen Strategien zur Myokardreparatur“,… 

more »Fischschwimmblasen bei der Behandlung von Herzversagen nützlich

Bakterien steuern die Fortpflanzung von Quallen

Mikrobiologinnen der Uni Kiel haben nachgewiesen, dass die asexuelle Fortpflanzung der Ohrenqualle maßgeblich durch bakterielle Produkte gesteuert wird. Dabei spielt Beta-Carotin, das von Mikroben im natürlichen Mikrobiom der Qualle produziert wird, eine Schlüsselrolle. Fehlen diese Mikroorganismen, kommt der so genannte Strobilationsprozess – die Verwandlung des Polypen bis hin zu jungen Medusen – zum Stillstand. Die […] Bakterien steuern die Fortpflanzung von Quallen

Research and Development in the United Arab Emirates: Focus on Medicine and Biotechnology

  • News

The Evolving Landscape of Biotechnology in the UAE The United Arab Emirates has positioned itself as an emerging powerhouse in biotechnology and medical research, driven by significant government initiatives and strategic investments. The nation’s commitment to diversifying its economy beyond oil has led to substantial focus on developing the life sciences sector, with biotechnology identified as a key sub-sector in Abu Dhabi’s Vision 2030[12]. This commitment is reflected in the establishment of dedicated biotech hubs, advanced research facilities, and partnerships with global industry leaders. The UAE’s biotechnology market has witnessed remarkable growth, largely attributable to the government’s dedication to enhancing the healthcare system and fostering innovation[1]. By 2025, the UAE aims to establish itself as a leading biotechnology destination, with particular emphasis on research and development in precision medicine and agricultural biotechnology[1]. The strategic location of the UAE, combined with… 

more »Research and Development in the United Arab Emirates: Focus on Medicine and Biotechnology

Sino-African technology relations on the rise: Experts call for closer cooperation

Nairobi, April 7, 2025 – Technological cooperation between China and Africa is entering a new era of deepening engagement. With the launch of the 2025–2027 Action Plan, decided at last year's Forum on China-Africa Cooperation (FOCAC) in Beijing, experts are now focusing on a more comprehensive partnership. The focus is on digital infrastructure, the promotion of the digital economy, and the modernization of agriculture – areas of central importance for Africa's development. A striking example of past cooperation is the Mombasa-Nairobi Standard Gauge Railway, built by China, which has revolutionized Kenya's transport infrastructure since its completion in 2017. Such projects are now to be complemented by technological innovations. Dennis Munene, Executive Director of the China-Africa Center at the Africa Policy Institute in Kenya, emphasized that China is developing technologies that could help Africa with challenges such as climate change. "We expect solutions such as drought-resistant… 

more »Sino-African technology relations on the rise: Experts call for closer cooperation